L. Kuvathérapie and .. , 58 b), p.58

L. Traitements-combinés-À-la-photothérapie and .. , 59 a) Les corticostéroïdes associés à la photothérapie, p.59

.. Prévenir-le-phénomène-de-koebner, 62 a) Les vêtements et accessoires

A. Et-physiologie-de-la-peau, Disponible sur: http://www.cancer.ca 3. Tobin D. Aging of the hair follicle pigmentation system, Consulté le 11 octobre 2015], p.83, 2009.

A. Taieb, V. Orphanet, M. Whitton, N. Van-geel, and . Vitiligo, Vitiligo [En ligne]. [Consulté le 1 mars 2015] Disponible sur: http://www.orpha, The Lancet. juill, vol.386, issue.9988, pp.74-84, 2015.

K. Ezzedine, H. Lim, T. Suzuki, I. Katayama, I. Hamzavi et al., Revised classification/nomenclature of vitiligo and related issues: the Vitiligo Global Issues Consensus Conference, Pigment Cell & Melanoma Research, vol.7, issue.Suppl, pp.1-13, 2012.
DOI : 10.1111/j.1755-148X.2012.00997.x

L. Vitiligo, Disponible sur: http://www.orpha.net 9. Illustrations Dermato-info: http://dermato-info.fr Wikipédia: wikipedia.org dermatobordeaux: http://www.dermatobordeaux.fr/images Children hospigal of Chicago, 2002.

S. Moretti and . Vitiligo, article de revue pour professionnels. Orphanet Encyclopedia, octobre 2003

S. Hann, Y. Park, W. Chun, S. Hann, and H. Lee, Clinical features of vitiligo Segmental vitiligo: clinical findings in 208 patients Pt 1):671?4. 13. Picardo M, Taieb A. The Neurogenic Hypothesis in Segmental Vitiligo, ):891?7. 12, pp.302-307, 1996.

D. Kim, S. Oh, and S. Hann, Classification of segmental vitiligo on the face: clues for prognosis, ):1004?9. 15. Picardo M, Taieb A. Segmental Vitiligo, pp.42-51, 2011.
DOI : 10.1111/j.1365-2133.2010.10202.x

L. Vitiligo, Physiopathologie et traitements: état des connaissance en 2010, Thèse de Pharmacie]. Nantes, 2010.

K. Gopal, R. Rao, G. Kumar, Y. , A. Rao et al., Vitiligo: A part of a systemic autoimmune process, Indian Journal of Dermatology, Venereology and Leprology, vol.73, issue.3, pp.162-167, 2007.
DOI : 10.4103/0378-6323.32710

Y. Gauthier, The importance of Koebner's phenomenon in the induction of vitiligo vulgaris lesions, EJD Eur J Dermatol, vol.5, issue.8, pp.704-712, 1995.

I. Hamzavi, H. Jain, D. Mclean, J. Shapiro, H. Zeng et al., Parametric Modeling of Narrowband UV-B Phototherapy for Vitiligo Using a Novel Quantitative Tool, ):677?83. 21. Taïeb A27?35. 22. Freiman A., Gratton D. Centre universitaire de santé McGill Vitiligo. Dermatologie. Conférence scientifiques, n°5, p.68, 2004.
DOI : 10.1001/archderm.140.6.677

N. Rezaei, N. Gavalas, A. Weetman, and E. Kemp, Autoimmunity as an aetiological factor in vitiligo propionate versus 1% pimecrolimus ointment in vitiligo, J Eur Acad Dermatol Venereol JEADV. août European journal of dermatology, vol.21, issue.15, pp.88-91, 2005.

E. Kemp, E. Waterman, B. Hawes, O. Neill, K. Gottumukkala et al., The melanin-concentrating hormone receptor 1, a novel target of autoantibody responses in vitiligo Local Immune Response in Skin of Generalized Vitiligo Patients. Destruction of melanocytes is associated with the proeminent presence of CLA+T cells at the perilesional site, Picardo M, Taieb A. Oxidative stress. In: Vitiligo. p, pp.1299-3091299, 2000.

M. Cucchi, P. Frattini, G. Santagostino, and G. Orecchia, Higher Plasma Catecholamine and Metabolite Levels in the Early Phase of Nonsegmental Vitiligo, Pigment Cell Research, vol.13, issue.1, pp.28-32, 2000.
DOI : 10.1034/j.1600-0749.2000.130106.x

S. Hasse, N. Gibbons, H. Rokos, L. Marles, and K. Schallreuter, Perturbed 6-Tetrahydrobiopterin Recycling via Decreased Dihydropteridine Reductase in Vitiligo: More Evidence for H2O2 Stress Schallreuter KU. Successful treatment of oxidative stress in vitiligo, J Invest Dermatol. févr Skin Pharmacol Appl Skin Physiol. juin, vol.12212, issue.23, pp.307-320, 1999.

M. Dell-'anna, V. Maresca, S. Briganti, E. Camera, M. Falchi et al., Mitochondrial Impairment in Peripheral Blood Mononuclear Cells During the Active Phase of Vitiligo, Journal of Investigative Dermatology, vol.117, issue.4, pp.908-921, 2001.
DOI : 10.1046/j.0022-202x.2001.01459.x

N. Laddha, M. Dwivedi, M. Mansuri, A. Gani, M. Ansarullah et al., Vitiligo: interplay between oxidative stress and immune system, Experimental Dermatology, vol.24, issue.4, pp.245-50, 2013.
DOI : 10.1111/exd.12103

L. Denat, A. Kadekaro, L. Marrot, S. Leachman, and Z. Malek, Melanocytes as instigators and victims of oxidative stress):1512?8. 38. Nordlund JJ. The epidemiology and genetics of vitiligo, J Invest Dermatol. juin Clin Dermatol. déc, vol.13415, issue.66, pp.875-883, 1997.

A. Alkhateeb, P. Fain, A. Thody, D. Bennett, and R. Spritz, Epidemiology of Vitiligo and Associated Autoimmune Diseases in Caucasian Probands and Their Families, Pigment Cell Research, vol.46, issue.3, pp.208-222, 2003.
DOI : 10.1034/j.1600-0749.2003.00032.x

A. Alkhateeb, G. Stetler, W. Old, J. Talbert, C. Uhlhorn et al., Mapping of an autoimmunity susceptibility locus (AIS1) to chromosome 1p31.3-p32.2, Human Molecular Genetics, vol.11, issue.6, pp.661-668, 2002.
DOI : 10.1093/hmg/11.6.661

M. Buc, H. Fazekasová, E. Cechová, E. Hegyi, K. Kolibásová et al., Occurrence rates of HLA-DRB1, HLA-DQB1, and HLA-DPB1 alleles in patients suffering from vitiligo, Eur J Dermatol EJD. févr, vol.8, issue.1, pp.13-18, 1998.

G. Laberge, D. Bennett, P. Fain, R. Spritz, K. Gowan et al., PTPN22 is genetically associated with risk of generalized vitiligo, but CTLA4 is not Novel vitiligo susceptibility loci on chromosomes 7 (AIS2) and 8 (AIS3), confirmation of SLEV1 on chromosome 17, and their roles in an autoimmune diathesis, J Invest Dermatol. juill Am J Hum Genet. janv, vol.12874, issue.71, pp.188-91, 2004.

Y. Jin, C. Mailloux, K. Gowan, S. Riccardi, G. Laberge et al., NALP1 in vitiligo-associated multiple autoimmune disease, 1216?25. 45. Spritz R. Genetics. Vitiligo, M. Picardo and A. Taieb, pp.155-164, 2007.

B. Kurien, K. Hensley, M. Bachmann, and R. Scofield, Oxidatively modified autoantigens in autoimmune diseases, Free Radical Biology and Medicine, vol.41, issue.4, pp.549-56, 2006.
DOI : 10.1016/j.freeradbiomed.2006.05.020

N. Laddha, M. Dwivedi, M. Mansuri, M. Singh, A. Gani et al., Role of oxidative stress and autoimmunity in onset and progression of vitiligo, Experimental Dermatology, vol.23, issue.5, pp.352-355, 2014.
DOI : 10.1111/exd.12372

J. Mazereeuw-hautier, S. Bezio, E. Mahe, C. Bodemer, C. Eschard et al., Segmental and nonsegmental childhood vitiligo has distinct clinical characteristics: a prospective observational study Koebner's phenomenon in vitiligo: European position paper Photo(chemo)therapy for vitiligo The treatment of hypopigmentation in children, ):945?9. 49. van Geel N564?73. 50. Pacifico A261?77. 51. Schaffer JV, Bolognia JL, pp.1-6, 2001.

P. Allain, R. Falabella, and M. Barona, Pharmacorama -Glucocorticoïdes -Effets, indications et effets indésirables [En ligne]. [Consulté le 29 octobre 2015] Disponible sur: http://www.pharmacorama.com 54 Update on skin repigmentation therapies in vitiligo, Pigment Cell Melanoma Res. févr, vol.22, issue.1, pp.42-65, 2009.

P. Dorosz, D. Durand, L. Jeunne, and C. , Guide pratique des médicaments. Paris: Maloine, 2014.

R. Faria, A. Tarlé, R. Dellatorre, G. Mira, M. et al., Vitiligo - Part 2 - classification, histopathology and treatment, Anais Brasileiros de Dermatologia, vol.89, issue.5, pp.784-90, 2014.
DOI : 10.1590/abd1806-4841.20142717

A. Borderé, J. Lambert, and N. Van-geel, Current and emerging therapy for the management of vitiligo, Clin Cosmet Investig Dermatol CCID. 12 mars, vol.2, pp.15-25, 2009.

A. Européen, D. Médicament, . Rcp, and . Protopic, Agence Européene du Médicament [En ligne] Disponible sur: www.ema.europa.eu 59. Luger T, Paul C. Potential new indications of topical calcineurin inhibitors, Dermatol Basel Switz, vol.215, issue.1, pp.45-54, 2007.

G. Leone and A. Pacifico, Profile of clinical efficacy and safety of topical tacalcitol, Acta Bio-Medica Atenei Parm. avr, vol.76, issue.1, pp.13-22, 2005.

Y. Zhang, J. Mooneyan-ramchurn, N. Zuo, Y. Feng, and X. S. , Vitiligo nonsurgical treatment: a review of latest treatment researches, Dermatologic Therapy, vol.168, issue.5, 2014.
DOI : 10.1111/dth.12143

J. Fenton, K. Bergstrom, D. Gupta, and R. Kumari, Vitiligo: nonsurgical treatment options and the evidence behind their use Depigmentation therapies in vitiligo, J Drugs Dermatol JDD. juill Indian J Dermatol Venereol Leprol, vol.778, issue.71, p.49, 2008.

D. Parsad, S. Gupta, . Iadvl-dermatosurgery-task, and . Force, Standard guidelines of care for vitiligo surgery, Indian J Dermatol Venereol Leprol. janv, vol.74, pp.37-45, 2008.

Y. Gauthier, Les techniques de greffe mélanocytaire Annales de dermatologie et de vénérologie, pp.627-631, 1995.

Y. Gauthier, Traitement des achromies par transplantation de mélanocytes. Encyclopédie médicochirurgicale . Éditions scientifiques et médicales Cosmétologie et dermatologie esthétique, 50-390-A-10, pp.1-6, 2000.

R. Falabella, Treatment of Localized Vitiligo by Autologous Minigrafting, Archives of Dermatology, vol.124, issue.11, pp.1649-55, 1988.
DOI : 10.1001/archderm.1988.01670110009002

R. Sarkar, S. Mehta, A. Kanwar, B. Boersma, W. Westerhof et al., Repigmentation after autologous miniature punch grafting in segmental vitiligo in North Indian patients Repigmentation in vitiligo vulgaris by autologous minigrafting: results in nineteen patients, ):990?5. 71. Kovacs SO. Vitiligo, pp.647-66, 1995.

S. Gupta, V. Jain, P. Saraswat, K. Ongenae, and J. Naeyaert, Suction blister epidermal grafting versus punch skin grafting in recalcitrant and stable vitiligo Dermatol Surg Off Publ Am Soc Dermatol Surg Al Surgical techniques for vitiligo: a review, 955?8. 73. van Geel N, pp.162-168, 1999.

M. Ozdemir, O. Cetinkale, R. Wolf, A. Koto?yan, C. Mat et al., Comparison of two surgical approaches for treating vitiligo: a preliminary study, International Journal of Dermatology, vol.77, issue.3, pp.135-143, 2002.
DOI : 10.1001/archderm.134.12.1543

M. Njoo, W. Westerhof, J. Bos, and P. Bossuyt, A Systematic Review of Autologous Transplantation Methods in Vitiligo, Archives of Dermatology, vol.134, issue.12, pp.1543-1552, 1998.
DOI : 10.1001/archderm.134.12.1543

M. Rusfianti and Y. Wirohadidjodjo, Dermatosurgical techniques for repigmentation of vitiligo Autologous grafting with noncultured melanocytes: a simplified method for treatment of depigmented lesions Pt 1):191?4. 78. Mulekar SV. Long-term follow-up study of 142 patients with vitiligo vulgaris treated by autologous, non-cultured melanocyte-keratinocyte cell transplantation, 411?7. 77. Gauthier Y, Surleve-Bazeille JE, pp.841-846, 1992.

Y. Chen, P. Yang, D. Hu, F. Kuo, C. Hung et al., Treatment of vitiligo by transplantation of cultured pure melanocyte suspension: analysis of 120 cases Treatment of vitiligo with a topical application of pseudocatalase and calcium in combination with short-term UVB exposure: a case study on 33 patients, 68?74. 80, pp.223-232, 1995.

L. Andreassi, E. Pianigiani, A. Andreassi, P. Taddeucci, M. Biagioli et al., A new model of epidermal culture for the surgical treatment of vitiligo Treatment of refractory and stable vitiligo by transplantation of in vitro cultured epidermal autografts bearing melanocytes Autologous miniature punch skin grafting in stable vitiligo Current state of vitiligo therapy--evidence-based analysis of the literature, 595?8. 82. Falabella R, pp.310467-75, 1992.

T. Dermatologique-un-manuel-de-référence-en-dermatologie-schallreuter, K. Wood, J. Ziegler, I. Lemke, K. Pittelkow et al., Disponible sur: http://www.therapeutiquedermatologique .org/ 86 Defective tetrahydrobiopterin and catecholamine biosynthesis in the depigmentation disorder vitiligo, Consulté le 31 octobre 2015], pp.181-92, 1994.

M. Tjioe, M. Gerritsen, L. Juhlin, P. Van-de-kerkhof, L. Felsten et al., Treatment of vitiligo vulgaris with narrow band UVB (311 nm) for one year and the effect of addition of folic acid and vitamin B12 Vitiligo: a comprehensive overview Part II: treatment options and approach to treatment, 493?514. 89. Société Française de Photodermatologie. Photodermatologie. Photobiologie cutanée, photoprotection et photothérapie. 2ème édition. Éditions Arnette, pp.369-72, 2002.

Y. Kwok, A. Anstey, J. Hawk, J. Parrish, and K. Jaenicke, Psoralen photochemotherapy (PUVA) is only moderately effective in widespread vitiligo: a 10-year retrospective study Action spectrum for phototherapy of psoriasis, 104?10. 91):359 ?62. 92. Picardo M, Taieb A. UVB total Body and Targeted phototherapies, pp.353-65, 1981.

. Le-traitement-du-vitiligo-par-laser-excimère, Réalités thérapeutiques en dermatovénérologie 94. Westerhof W, Nieuweboer-Krobotova L. Treatment of vitiligo with UV-B radiation vs topical psoralen plus UV-A, Arch Dermatol. déc, vol.133, issue.12, pp.1525-1533, 1997.

B. Mahmoud, C. Hexsel, and I. Hamzavi, An update on new and emerging options for the treatment of vitiligo, Skin Ther Lett. mars, vol.13, issue.2, pp.1-6, 2008.

E. Mofty, M. Mostafa, W. Esmat, S. Youssef, R. Azzam et al., Narrow band Ultraviolet B 311 nm in the treatment of vitiligo: two right-left comparison studies 308-nm excimer laser for the treatment of localized vitiligo, Photodermatol Photoimmunol Photomed. févr Int J Dermatol. août, vol.2242, issue.18, pp.658-62, 2003.

T. Passeron, N. Ostovari, W. Zakaria, E. Fontas, J. Larrouy et al., Topical Tacrolimus and the 308-nm Excimer Laser, Archives of Dermatology, vol.140, issue.9, pp.1065-1074, 2004.
DOI : 10.1001/archderm.140.9.1065

S. Hadi, P. Tinio, K. Al-ghaithi, H. Qari, M. Helalat et al., Treatment of Vitiligo Using the 308-nm Excimer Laser, Photomedicine and Laser Surgery, vol.24, issue.3, pp.354-361, 2006.
DOI : 10.1089/pho.2006.24.354

N. Ostovari, T. Passeron, W. Zakaria, E. Fontas, J. Larouy et al., Treatment of vitiligo by 308-nm excimer laser: An evaluation of variables affecting treatment response, Lasers in Surgery and Medicine, vol.134, issue.2, pp.152-158, 2004.
DOI : 10.1002/lsm.20057

M. Casacci, P. Thomas, A. Pacifico, A. Bonnevalle, P. Vidolin et al., Comparison between 308-nm monochromatic excimer light and narrowband UVB phototherapy (311-313??nm) in the treatment of vitiligo - a multicentre controlled study, Journal of the European Academy of Dermatology and Venereology, vol.20, issue.7
DOI : 10.1111/j.1468-3083.2007.02151.x

S. Valkova, M. Trashlieva, and P. Christova, Treatment of vitiligo with local khellin and UVA: comparison with systemic PUVA, Clinical and Experimental Dermatology, vol.31, issue.2, pp.180-184, 2004.
DOI : 10.1001/archderm.133.12.1530

G. Menchini, E. Tsoureli-nikita, and J. Hercogova, Narrow-band UV-B micro-phototherapy: a new treatment for vitiligo, Journal of the European Academy of Dermatology and Venereology, vol.116, issue.1, pp.171-178, 2003.
DOI : 10.1016/S0926-9959(99)00087-2

D. Parsad, R. Pandhi, S. Dogra, and B. Kumar, Clinical study of repigmentation patterns with different treatment modalities and their correlation with speed and stability of repigmentation in 352 vitiliginous patches, Journal of the American Academy of Dermatology, vol.50, issue.1, pp.63-70, 2004.
DOI : 10.1016/S0190-9622(03)00786-2

F. Sassi, S. Cazzaniga, G. Tessari, L. Chatenoud, A. Reseghetti et al., Randomized controlled trial comparing the effectiveness of 308-nm excimer laser alone or in combination with topical hydrocortisone 17-butyrate cream in the treatment of vitiligo of the face and neck, British Journal of Dermatology, vol.157, issue.5, pp.1186-91, 2008.
DOI : 10.1111/j.1365-2133.2008.08793.x

D. Gawkrodger, A. Ormerod, L. Shaw, I. Mauri-sole, M. Whitton et al., Guideline for the diagnosis and management of vitiligo, British Journal of Dermatology, vol.5, issue.5, pp.1051-76, 2008.
DOI : 10.1111/j.1365-2133.2008.08881.x

E. Goktas, F. Aydin, N. Senturk, M. Canturk, and A. Turanli, Combination of narrow band UVB and topical calcipotriol for the treatment of vitiligo, Journal of the European Academy of Dermatology and Venereology, vol.37, issue.5
DOI : 10.1046/j.1468-3083.2003.00795.x

S. Goldinger, R. Dummer, P. Schmid, G. Burg, B. Seifert et al., Combination of 308-nm xenon chloride excimer laser and topical calcipotriol in vitiligo, Journal of the European Academy of Dermatology and Venereology, vol.31, issue.0, pp.504-512, 2007.
DOI : 10.1111/j.1524-4725.2004.30058.x

H. Seirafi, M. Daneshpazhouh, S. Khezri, S. Rad, and S. , 308-nm excimer laser plus topical calcipotriol in the treatment of vitiligo; A single blind randomized clinical study, Iranian Journal of Dermatology Iranian Society of Dermatology. Disponible sur, 2011.

A. Kawalek, J. Spencer, and R. Phelps, Combined Excimer Laser and Topical Tacrolimus for the Treatment of Vitiligo, Dermatologic Surgery, vol.30, issue.2, pp.130-135, 2004.
DOI : 10.1097/00042728-200402000-00002

D. Fai, N. Cassano, and G. Vena, Narrow-band UVB phototherapy combined with tacrolimus ointment in vitiligo: a review of 110 patients, Journal of the European Academy of Dermatology and Venereology, vol.153, issue.7, pp.916-936, 2007.
DOI : 10.1111/j.1468-3083.2006.02101.x

T. Lotti, G. Buggiani, M. Troiano, G. Assad, J. Delescluse et al., Targeted and combination treatments for vitiligo???Comparative evaluation of different current modalities in 458 subjects, Dermatologic Therapy, vol.142, issue.1, pp.20-26, 2008.
DOI : 10.1111/j.1529-8019.2008.00198.x

Y. Jang, S. Jung, J. Shin, and H. Kang, Triple Combination of Systemic Corticosteroids, Excimer Laser, and Topical Tacrolimus in the Treatment of Recently Developed Localized Vitiligo, Annals of Dermatology, vol.27, issue.1, p.104, 2015.
DOI : 10.5021/ad.2015.27.1.104

J. Bae, H. Yoo, H. Kim, J. Lee, and G. Kim, Combination therapy with 308-nm excimer laser, topical tacrolimus, and short-term systemic corticosteroids for segmental vitiligo: A retrospective study of 159 patients, Journal of the American Academy of Dermatology, vol.73, issue.1, pp.76-82, 2015.
DOI : 10.1016/j.jaad.2015.04.008

H. Lim, P. Grimes, O. Agbai, I. Hamzavi, M. Henderson et al., Afamelanotide and Narrowband UV-B Phototherapy for the Treatment of Vitiligo, JAMA Dermatology, vol.151, issue.1, pp.42-50, 2015.
DOI : 10.1001/jamadermatol.2014.1875

P. Grimes, I. Hamzavi, M. Lebwohl, J. Ortonne, and H. Lim, The Efficacy of Afamelanotide and Narrowband UV-B Phototherapy for Repigmentation of Vitiligo, JAMA Dermatology, vol.149, issue.1, pp.68-73, 2013.
DOI : 10.1001/2013.jamadermatol.386

Y. Gauthier, T. Jouary, S. Boutchenei, A. Taieb, and K. Ezzedine, Conseils pratiques pour le Vitiligo [En ligne]. [Consulté le 1 mars 2015, Disponible sur